Louis Ledan, PharmD

Interactions between nirmatrelvir/ritonavir and direct oral anticoagulants is complicated, and a point of contrasting views between the US and EU medical communities.

Despite the surge in new diabetes cases, the treatment options in in children remain limited.

Indication can play a major role in pharmacists recommending brain health products.

Insurance companies are currently investigating the option of modifying which medications they will cover for HIV pre-exposure prophylaxis (PrEP) therapy, with broad implications for patient access.

Adding a few practices to one’s daily routine can help to mitigate the effects from some of the challenges in daily life that can impair mental cognition.